However, the “aggressive CRC phenotype” may be characterized by dedifferentiation, i.e., the loss of the differentiation marker, production of aberrant cytokeratin 7, and eventual high production of a neo-antigen, i.e., PD-L1. This evidence concerns the gene KRT7 and colorectal carcinoma.